256 related articles for article (PubMed ID: 29633922)
1. Recent advances in magnetic resonance imaging for peripheral artery disease.
Mathew RC; Kramer CM
Vasc Med; 2018 Apr; 23(2):143-152. PubMed ID: 29633922
[TBL] [Abstract][Full Text] [Related]
2. Magnetic Resonance Imaging Techniques in Peripheral Arterial Disease.
Hosadurg N; Kramer CM
Adv Wound Care (New Rochelle); 2023 Nov; 12(11):611-625. PubMed ID: 37058352
[No Abstract] [Full Text] [Related]
3. Turbo spin-echo-based enhanced acceleration-selective arterial spin labeling without electrocardiography or peripheral pulse unit triggering and contrast enhancement for lower extremity MRA.
Konta N; Shibukawa S; Horie T; Niwa T; Obara M; Okazaki T; Kawamura Y; Miyati T
Magn Reson Imaging; 2024 Jul; 110():43-50. PubMed ID: 38604346
[TBL] [Abstract][Full Text] [Related]
4. Intracranial 3D and 4D MR Angiography Using Arterial Spin Labeling: Technical Considerations.
Suzuki Y; Fujima N; van Osch MJP
Magn Reson Med Sci; 2020 Dec; 19(4):294-309. PubMed ID: 31761840
[TBL] [Abstract][Full Text] [Related]
5. Whole-body MR angiography in patients with peripheral arterial disease.
Nielsen YJ
Dan Med Bull; 2010 Dec; 57(12):B4231. PubMed ID: 21122468
[TBL] [Abstract][Full Text] [Related]
6. Image Quality and Stenosis Assessment of Non-Contrast-Enhanced 3-T Magnetic Resonance Angiography in Patients with Peripheral Artery Disease Compared with Contrast-Enhanced Magnetic Resonance Angiography and Digital Subtraction Angiography.
Liu J; Zhang N; Fan Z; Luo N; Zhao Y; Bi X; An J; Chen Z; Liu D; Wen Z; Fan Z; Li D
PLoS One; 2016; 11(11):e0166467. PubMed ID: 27861626
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis of renal artery stenosis with magnetic resonance angiography and stenosis quantification].
Marchand B; Hernandez-Hoyos M; Orkisz M; Douek P
J Mal Vasc; 2000 Dec; 25(5):312-320. PubMed ID: 11148391
[TBL] [Abstract][Full Text] [Related]
8. Arterial spin labeling MR imaging reproducibly measures peak-exercise calf muscle perfusion: a study in patients with peripheral arterial disease and healthy volunteers.
Pollak AW; Meyer CH; Epstein FH; Jiji RS; Hunter JR; Dimaria JM; Christopher JM; Kramer CM
JACC Cardiovasc Imaging; 2012 Dec; 5(12):1224-30. PubMed ID: 23236972
[TBL] [Abstract][Full Text] [Related]
9. Noncontrast Magnetic Resonance Angiography for the Diagnosis of Peripheral Vascular Disease.
Cavallo AU; Koktzoglou I; Edelman RR; Gilkeson R; Mihai G; Shin T; Rajagopalan S
Circ Cardiovasc Imaging; 2019 May; 12(5):e008844. PubMed ID: 31088154
[TBL] [Abstract][Full Text] [Related]
10. Arterial spin-labeling MR imaging in Moyamoya disease compared with clinical assessments and other MR imaging findings.
Noguchi T; Kawashima M; Nishihara M; Hirai T; Matsushima T; Irie H
Eur J Radiol; 2013 Dec; 82(12):e840-7. PubMed ID: 24055185
[TBL] [Abstract][Full Text] [Related]
11. MRI for peripheral artery disease: Introductory physics for vascular physicians.
Roy TL; Forbes TL; Dueck AD; Wright GA
Vasc Med; 2018 Apr; 23(2):153-162. PubMed ID: 29534646
[TBL] [Abstract][Full Text] [Related]
12. Convolutional Neural Networks to Study Contrast-Enhanced Magnetic Resonance Imaging-Based Skeletal Calf Muscle Perfusion in Peripheral Artery Disease.
Khagi B; Belousova T; Short CM; Taylor AA; Bismuth J; Shah DJ; Brunner G
Am J Cardiol; 2024 Jun; 220():56-66. PubMed ID: 38580040
[TBL] [Abstract][Full Text] [Related]
13. Multifactorial determinants of functional capacity in peripheral arterial disease: uncoupling of calf muscle perfusion and metabolism.
Anderson JD; Epstein FH; Meyer CH; Hagspiel KD; Wang H; Berr SS; Harthun NL; Weltman A; Dimaria JM; West AM; Kramer CM
J Am Coll Cardiol; 2009 Aug; 54(7):628-35. PubMed ID: 19660694
[TBL] [Abstract][Full Text] [Related]
14. Peripheral MR Angiography.
Kramer JH; Grist TM
Magn Reson Imaging Clin N Am; 2012 Nov; 20(4):761-76. PubMed ID: 23088949
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced peripheral MRA: technique and contrast agents.
Nielsen YW; Thomsen HS
Acta Radiol; 2012 Sep; 53(7):769-77. PubMed ID: 22843836
[TBL] [Abstract][Full Text] [Related]
16. Initial evaluation of non-contrast-enhanced magnetic resonance angiography in patients with peripheral arterial occlusive disease at 7 T.
Fischer A; Maderwald S; Johst S; Orzada S; Ladd ME; Umutlu L; Lauenstein TC; Kniemeyer HW; Nassenstein K
Invest Radiol; 2014 May; 49(5):331-8. PubMed ID: 24637590
[TBL] [Abstract][Full Text] [Related]
17. Advances in non-contrast quiescent-interval slice-selective (QISS) magnetic resonance angiography.
Edelman RR; Carr M; Koktzoglou I
Clin Radiol; 2019 Jan; 74(1):29-36. PubMed ID: 29336780
[TBL] [Abstract][Full Text] [Related]
18. Peripheral arterial disease assessment: wall, perfusion, and spectroscopy.
Kramer CM
Top Magn Reson Imaging; 2007 Oct; 18(5):357-69. PubMed ID: 18025990
[TBL] [Abstract][Full Text] [Related]
19. Dixon-based fat-free MR-angiography compared to first pass and steady-state high-resolution MR-angiography using a blood pool contrast agent.
Homsi R; Gieseke J; Kukuk GM; Träber F; Willinek WA; Schild HH; Hadizadeh DR
Magn Reson Imaging; 2015 Nov; 33(9):1035-1042. PubMed ID: 26220860
[TBL] [Abstract][Full Text] [Related]
20. 3 T contrast-enhanced magnetic resonance angiography for evaluation of the intracranial arteries: comparison with time-of-flight magnetic resonance angiography and multislice computed tomography angiography.
Villablanca JP; Nael K; Habibi R; Nael A; Laub G; Finn JP
Invest Radiol; 2006 Nov; 41(11):799-805. PubMed ID: 17035870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
